Related Experiment Video

Updated: Jan 21, 2026

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
05:39

Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia

Published on: May 26, 2023

2.3K

Risk factors for pneumonia in the intubated patient

Olga Diaz1, Emili Diaz, Jordi Rello

  • 1Critical Care Department, Hospital Doce de Octubre, Madrid, Spain.

Infectious Disease Clinics of North America
|March 11, 2004
PubMed

Insights

Antibiotic therapy for ventilator-associated pneumonia (VAP) has a dual effect. While initially protective, prolonged use promotes resistant pathogens, increasing mortality risk.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Ventilator-associated pneumonia (VAP) is a significant complication in mechanically ventilated patients.
  • Understanding VAP risk factors is crucial for effective prevention and treatment strategies.
  • Previous studies show conflicting results regarding antibiotic efficacy in VAP.

Purpose of the Study:

  • To elucidate the variable risk factors associated with VAP development.
  • To explain the opposing effects of antibiotics observed in different investigations.
  • To analyze the bimodal impact of antibiotic therapy on VAP.

Main Methods:

  • Review and synthesis of existing data on VAP risk factors and antibiotic effects.
  • Analysis of antibiotic's protective role in early VAP versus its role in promoting resistant pathogens.
  • Consideration of patient exposure variables like duration of mechanical ventilation (MV) and length of stay.

Main Results:

  • Antibiotic therapy demonstrates a bimodal effect on VAP development.
  • Early in mechanical ventilation (MV), antibiotics protect against VAP, particularly from endogenous flora.
  • Prolonged antibiotic use selects for resistant pathogens (e.g., P. aeruginosa, MRSA), increasing mortality.

Conclusions:

  • VAP risk factors are dynamic and depend on exposure duration (length of stay, MV).
  • The observed variability in risk factors and antibiotic effects is explained by this bimodal antibiotic action.
  • Future VAP prophylaxis trials and risk factor analyses must account for patient exposure variables.

More Related Videos

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.6K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
307
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
760
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.7K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Endotracheal Intubation I: Procedure01:15

Endotracheal Intubation I: Procedure

Endotracheal or ET intubation is a critical medical procedure used to secure a patient's airway, often in acute respiratory distress, apnea, upper airway obstruction, ineffective clearance of secretions, high risk for aspiration, or during general anesthesia.
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
7.7K